President and CEO of Gilead Sciences Inc (GILD, Financial) John F Milligan sold 112,000 shares of GILD on 07/05/2016 at an average price of $84.33 a share. The total sale was $9.4 million.
Gilead Sciences Inc is a research-based biopharmaceutical company that discovers, develops and commercializes new medicines for different medical sectors. Gilead Sciences Inc has a market cap of $113.83 billion; its shares were traded at around $85.47 with a P/E ratio of 7.30 and P/S ratio of 3.90. The dividend yield of Gilead Sciences Inc stocks is 2.06%. Gilead Sciences Inc had an annual average EBITDA growth of 27.20% over the past 5 years.
CEO Recent Trades:
- President and CEO John F Milligan sold 112,000 shares of GILD stock on 07/05/2016 at the average price of $84.33. The price of the stock has increased by 1.35% since.
Directors and Officers Recent Trades:
- Executive Chairman John C Martin sold 100,000 shares of GILD stock on 07/01/2016 at the average price of $84.73. The price of the stock has increased by 0.87% since.
- EVP Commercial Ops Paul Rutherford Carter sold 2,000 shares of GILD stock on 07/01/2016 at the average price of $83.12. The price of the stock has increased by 2.83% since.
For the complete insider trading history of GILD, click here
.
